There are 2936 resources available
Live Q&A - 24 September 2020 - 15:30-16:00
Presenter: James Larkin
Session: Bristol Myers Squibb - Harnessing the Potential of the Immune System: Clinical Insights From Utilizing CTLA-4 Within a Dual I-O Approach in aRCC
Resources:
Webcast
Live Q&A - 18 September 2020 - 17:00-17:30
Presenter: Emile Voest
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast
Live Q&A - 23 September 2020 - 11:30-12:00
Presenter: Fortunato Ciardiello
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Welcome and Introduction
Presenter: Markus Möhler
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
Current status of I-O for the treatment of metastatic colorectal cancer
Presenter: Sara Lonardi
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
Welcome and introduction
Presenter: George Demetri
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
The patient perspective: The relevance of RWE in patient decision-making
Presenter: Renate Haidinger
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
The physician perspective: Using RWE to inform clinical decisions in day-to-day practice and drug discovery
Presenter: George Demetri
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
Welcome and Introduction
Presenter: James Larkin
Session: Bristol Myers Squibb - Harnessing the Potential of the Immune System: Clinical Insights From Utilizing CTLA-4 Within a Dual I-O Approach in aRCC
Resources:
Webcast
Deepening Our Understanding of Dual Checkpoint Inhibition
Presenter: Michael Atkins
Session: Bristol Myers Squibb - Harnessing the Potential of the Immune System: Clinical Insights From Utilizing CTLA-4 Within a Dual I-O Approach in aRCC
Resources:
Webcast